Trial intelligence / Profile preview

Propofol anesthesia depth and cerebral blood flow during intubation in supratentorial tumor surgery

ACTRN12617000580370Phase 4Terminated

Sponsor
achmet ali
Start
May 2017
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of propofol in brain neoplasm (2 arms), sponsored by achmet ali. Primary endpoint: Mean blood flow velocity of bilateral middle cerebral artery. Started May 2017; status: terminated.

02

Drugs

propofol
03

Conditions

brain neoplasm

Beyond the preview

Go deeper on ACTRN12617000580370.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ACTRN12617000580370.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call